Skip to content
Brand AI

North China Pharmaceutical

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Huabei Pharmaceutical barred from national drug procurement participation

    The National Drug Centralized Procurement Office placed Huabei Pharmaceutical on its violation list and cancelled its eligibility to apply for national centralized drug procurement from August 11, 2021 through May 10, 2022. The office said the company failed to supply the agreed quantity of ibuprofen sustained-release capsules in Shandong and had requested to give up its selected status.

    Source